Cancer is a complex diagnosis often requiring a high level of service and support from an expert care team focused on making sure patients understand their treatment regimen, comply with their therapy schedule, manage potential side effects, and have   (Read More)

One year ago, I wrote a blog for OHC on the rising increase of colon cancer in young adults ( Unfortunately, recent research underscores this reality and reinforces my strong endorsement of colon   (Read More)

This year, nearly two million Americans will receive a cancer diagnosis. If a friend or loved one shares their diagnosis with you, naturally, you will want to convey compassion and support, but it can be challenging to know exactly what to say. OHC   (Read More)

In 2013, April Becraft of Georgetown, Ohio, was a 32-year-old mother of a toddler and a baby and was teaching special education at an elementary school when she began to feel tired all the time. She attributed the fatigue to having a new baby, but   (Read More)

In January 2020, Danyell Weisinger of Hamilton, Ohio was working as a bank teller when she began to experience intense stomach pain. She took ibuprofen around the clock to muscle through it. Fortunately, her boss convinced her to see a doctor. X-rays   (Read More)

Just over a year ago, Carrie Carothers was in a dark place, facing a stage 2 non-Hodgkin lymphoma (NHL) diagnosis and worried for her husband and three children. Now in remission, this philanthropic mother has inspired her son to help find a cure for   (Read More)

OHC partners with US Oncology Research, an experienced network of more than 800 dedicated researchers who have played a role in more than 100 FDA approved cancer therapies. OHC’s leading cancer experts continue to make progress towards finding a   (Read More)

Every year, more than 25,000 Americans are diagnosed with diffuse large B-cell lymphoma (DLBCL), an aggressive cancer with a treatment journey that often poses a challenge to patients. About 30-40 percent of patients will relapse or have no response   (Read More)

OHC advanced practice provider and lead cancer genetic specialist, Andrew “Andy” Guinigundo, MSN, RN, CNP, ANP-BC, was recently elected to the Board of Directors of the Advanced Practitioner Society for Hematology and Oncology (APSHO), a society   (Read More)

According to a statement from The White House, more than 9.5 million cancer screenings in the U.S. were missed because of the COVID pandemic. Lockdowns, fear of exposure, and strained hospital resources have led to delayed screenings and treatment.   (Read More)

At age 71, James “Jim” Rueger, a retired attorney, had never been sick a day in his life. While enjoying one of his frequent visits to Anna Maria Island, Florida, he experienced shortness of breath and was bruising and bleeding excessively from a   (Read More)

Following a summer-like fall season, it is tempting to want to get outdoors and enjoy the delicate snowfall or help the grandkids build a snowman. Across the country, winter weather creates a high risk of car accidents, hypothermia and frostbite, and   (Read More)

Every day, I work alongside an extremely talented and compassionate group of cancer doctors. I am pleased to learn that their brilliance has not gone unnoticed. Every year, Cincinnati Magazine surveys the city’s doctors about their choice for   (Read More)

Cancer is a genetic disease, and about 10 percent of cancers are hereditary. At OHC, we not only treat cancer, we assess and manage the risk. Our cancer genetic specialists offer in-depth education, risk assessment, consultation, and genetic testing   (Read More)

According to the American Cancer Society, breast cancer is the most common cancer diagnosed among American women. About two out of three breast cancers are estrogen receptor-positive (ER+). Ongoing research is critical to develop new treatment   (Read More)